REG - FTSE Russell Hikma Pharmaceutical - Hikma Pharmaceuticals
RNS Number : 8326QFTSE Russell23 June 2020
Hikma Pharmaceuticals (UK): Shares in Issue and Investability Weight Change
Changes in FTSE UK Index Series23 June 2020
Following the receipt of updated shareholder information for Hikma Pharmaceuticals, (UK, constituent) as a result of a secondary placing and concurrent share repurchase, please see details of affected indexes and effective dates below:
Index
Effective From
Start of TradingFTSE 100 Index
26 June 2020
FTSE 350 Index
26 June 2020
FTSE All-Share Index
26 June 2020
FTSE 350 Lower Yield Index
26 June 2020
* The change to Index shares reflects the secondary placing only.
For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:
Australia
+1800 653 680
Hong Kong
+852 2164 3333
Japan
+81 3 4563 6346
London
+44 (0) 20 7866 1810
New York
+1866 551 0617
Alternatively please visit our website at www.ftserussell.com
Terms of Use | Copyright © 2020 FTSE Russell
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDFTSSEMFDDESSEIM
Recent news on Hikma Pharmaceuticals
See all newsREG - Hikma Pharmaceutical - Result of AGM
AnnouncementREG - Hikma Pharmaceutical - Trading Statement
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Hikma appoints new President of Generics business
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
Announcement